Click on one of these terms to refine your search
1 to 10 of 18 literature results
The authors examined neuropsychological functioning in 20 long-term (LT), 20 shorter term (ST) heavy frequent cannabis users, and 24 controls after ab…
Authors: Lambros Messinis, Anthoula Kyprianidou, Sonia Malefaki, Panagiotis Papathanasopoulos
Source: Neurology. 2006 Mar 14
View Full TextOn incubation with epinephrine, PC12 cells stably expressing alpha2-adrenergic receptor (alpha2-AR) undergo morphological and biochemical changes char…
Authors: Georgios Karkoulias, Orthodoxia Mastrogianni, Panagiotis Papathanasopoulos, Hervé Paris, Christodoulos Flordellis
Source: Journal of neurochemistry. 2007 Nov
View Full TextDerangement of cellular immunity is central in the pathophysiology of multiple sclerosis (MS) and is often manifested by abnormal cytokine production.…
Authors: George Deraos, Kokona Chatzantoni, Minos-Timotheos Matsoukas, Theodore Tselios, Spyros Deraos, Maria Katsara, Panagiotis Papathanasopoulos, Demitrios Vynios, Vasso Apostolopoulos, Athanasia Mouzaki,…
Source: Journal of medicinal chemistry. 2008 Dec 25
View Full TextAuthors: Lambros Messinis, Panagiotis Papathanasopoulos
Source: Neurology. 2009 Jan 6
View Full TextPURPOSE: In the present study, we examined relationships between neuropsychological functions and brain single photon emission computed tomography (SP…
Authors: Anna Paschali, Lambros Messinis, Epameinondas Lyros, Costas Constantoyannis, Zinovia Kefalopoulou, Velissarios Lakiotis, Panagiotis Papathanasopoulos, Paulos Vassilakos
Source: European journal of nuclear medicine and molecular imaging. 2009 Nov
View Full TextIn the frame of current treatment options for multiple sclerosis (MS) and recommendations for early intervention, we investigated the practice and att…
Authors: Panagiotis Papathanasopoulos, Lambros Messinis, Epameinondas Lyros, Anastasia Nikolakopoulou, Eftymia Gourzoulidou, Sonia Malefaki
Source: Journal of neurology. 2008 Dec
View Full TextBACKGROUND: The frequency of multiple sclerosis (MS) in Greece remains speculative, as data from many parts are still lacking. OBJECTIVE: To estimate …
Authors: Panagiotis Papathanasopoulos, Efthimia Gourzoulidou, Lambros Messinis, Vasillis Georgiou, Michalis Leotsinidis
Source: Neuroepidemiology. 2008
View Full TextResearch has recently focused on cognitive dysfunction in multiple sclerosis (MS). Cognitive deficits are frequently encountered in patients and accou…
Authors: Epameinondas Lyros, Lambros Messinis, Sokratis G Papageorgiou, Panagiotis Papathanasopoulos
Source: International review of psychiatry (Abingdon, England). 2010
View Full TextPatients with multiple sclerosis (MS) have a substantial risk of cognitive dysfunction, even in the earliest stages of the disease, where there is min…
Authors: Lambros Messinis, Mary H Kosmidis, Epameinondas Lyros, Panagiotis Papathanasopoulos
Source: International review of psychiatry (Abingdon, England). 2010
View Full TextAlthough once considered rare, several more recent investigations have been published describing psychotic features in multiple sclerosis (MS). The as…
Authors: Mary H Kosmidis, Maria Giannakou, Lambros Messinis, Panagiotis Papathanasopoulos
Source: International review of psychiatry (Abingdon, England). 2010
View Full Text